Journal
FRONTIERS IN PHYSIOLOGY
Volume 12, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fphys.2021.782525
Keywords
synthetic lipid; cell death; pancreas; signal transduction; oncology; autophagy; cancer
Categories
Funding
- Ministerio de Economia y Competitividad [RTC-2015-3542, RTC-2015-4094, RTC2019-007399-1]
- FEDER funds
- Govern de les Illes Balears
- European Social Fund [ES01/TCAI/53_2016, PROCOE/5/2017, ES01/TCAI/21_2017, ES01/TCAI/24_2018, FPI/1981/2016, FPI_063_2020]
- European Commission [755179]
- Spanish Ministerio de Economia y Competitividad [DI-14-06701]
- European Social Fund Investing in your future [PTQ-17-09056]
- Spanish Ministerio de Economia y Competitividad
- H2020 Societal Challenges Programme [755179] Funding Source: H2020 Societal Challenges Programme
Ask authors/readers for more resources
This study investigated the activity of a synthetic lipid, TGM4, on pancreatic cancer cells and found that it inhibited cell proliferation and induced cell death through the activation of cytocidal autophagy. These findings highlight the importance of lipid signaling in cancer and suggest synthetic lipid structures as potential approaches to treat pancreatic cancer and other neoplasias.
Cell proliferation in pancreatic cancer is determined by a complex network of signaling pathways. Despite the extensive understanding of these protein-mediated signaling processes, there are no significant drug discoveries that could considerably improve a patient's survival. However, the recent understanding of lipid-mediated signaling gives a new perspective on the control of the physiological state of pancreatic cells. Lipid signaling plays a major role in the induction of cytocidal autophagy and can be exploited using synthetic lipids to induce cell death in pancreatic cancer cells. In this work, we studied the activity of a synthetic lipid, tri-2-hydroxyarachidonein (TGM4), which is a triacylglycerol mimetic that contains three acyl moieties with four double bonds each, on cellular and in vivo models of pancreatic cancer. We demonstrated that TGM4 inhibited proliferation of Mia-PaCa-2 (human pancreatic carcinoma) and PANC-1 (human pancreatic carcinoma of ductal cells) in in vitro models and in an in vivo xenograft model of Mia-PaCa-2 cells. In vitro studies demonstrated that TGM4 induced cell growth inhibition paralleled with an increased expression of PARP and CHOP proteins together with the presence of sub-G(0) cell cycle events, indicating cell death. This cytocidal effect was associated with elevated ER stress or autophagy markers such as BIP, LC3B, and DHFR. In addition, TGM4 activated peroxisome proliferator-activated receptor gamma (PPAR-gamma), which induced elevated levels of p-AKT and downregulation of p-c-Jun. We conclude that TGM4 induced pancreatic cell death by activation of cytocidal autophagy. This work highlights the importance of lipid signaling in cancer and the use of synthetic lipid structures as novel and potential approaches to treat pancreatic cancer and other neoplasias.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available